Article
Between a bug and a hard place: Trypanosoma cruzi genetic diversity and the clinical outcomes of Chagas disease.
Expert review of anti-infective therapy - 1 Aug 2015
Messenger Louisa A, Miles Michael A, Bern Caryn
Abstract excerpt
Over the last 30 years, concomitant with successful transnational disease control programs across Latin America, Chagas disease has expanded from a neglected, endemic parasitic infection of the rural poor to an urbanized chronic disease, and now a potentially emergent global health problem. Trypanosoma cruzi infection has a highly variable clinical course, ranging from complete absence of symptoms to severe and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
